Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹61 Cr.
Stock P/E
14.4
P/B
1.5
Current Price
₹44.5
Book Value
₹ 29.9
Face Value
10
52W High
₹56.8
52W Low
₹ 34
Dividend Yield
—

Shanmuga Hospital Overview

Business

Shanmuga Hospital Ltd. operates within the Hospital & Healthcare Services sector in India. Its core business involves providing comprehensive medical care and healthcare services to patients. This typically includes inpatient services (hospitalization, surgery, critical care), outpatient consultations, diagnostic services (pathology, radiology), pharmacy services, and emergency care. The company generates revenue primarily through fees charged for these medical services, consultations, procedures, and related auxiliary services to patients.

Revenue Mix

While specific breakdowns are not available, typical revenue segments for a hospital company like Shanmuga Hospital Ltd. would include:

Inpatient Services: Revenue from hospitalized patients, including room charges, surgical fees, procedure costs, and intensive care.

Outpatient Services: Revenue from consultations, minor procedures, and day-care services.

Diagnostics: Revenue from laboratory tests (pathology) and imaging services (radiology).

Pharmacy: Revenue from dispensing medicines to both inpatients and outpatients.

Emergency & Other Services: Revenue from emergency room visits and other specialized treatments.

Industry

The Indian Hospital & Healthcare Services industry is characterized by a mix of public and private players, growing demand driven by population growth, increasing disposable incomes, and a rising burden of non-communicable diseases. It is fragmented, especially in tier 2 and tier 3 cities, with a few large corporate hospital chains and numerous standalone or regional hospitals. Given its ticker (SHANMUGA) and name, Shanmuga Hospital Ltd. is likely positioned as a regional or local healthcare provider, competing with other private hospitals, government healthcare facilities, and potentially smaller clinics in its operating geographies. Its positioning would depend on its specializations, quality of care, and brand reputation within its local market.

MOAT

For a hospital company, potential competitive advantages (moats) can include:

Brand & Reputation: A strong reputation for quality medical care, patient outcomes, and ethical practices built over time can foster trust and loyalty.

Doctor Talent & Specialization: The ability to attract and retain highly skilled doctors, specialists, and nursing staff, particularly in niche medical fields.

Location & Accessibility: Strategic locations that are easily accessible to a large patient base.

Local Network Effects/Switching Costs: For local patients, established relationships with doctors and familiarity with a facility can create minor switching costs.

Scale (Local): For a regional player, having a significant number of beds or specialized units in a particular region can offer some scale advantages in procurement and operational efficiency within that local market.

Growth Drivers

Increasing Healthcare Demand: Driven by India's large and growing population, rising life expectancy, and increasing prevalence of lifestyle diseases.

Rising Disposable Incomes: Allowing more individuals to opt for private healthcare facilities.

Health Insurance Penetration: Growing adoption of private health insurance and government schemes (e.g., Ayushman Bharat) expands access to private healthcare.

Medical Tourism: India's potential as a destination for medical tourists seeking quality treatment at competitive prices.

Infrastructure Expansion & Modernization: Investing in new facilities, bed capacity, and advanced medical technology.

Risks

Regulatory & Policy Changes: Evolving government regulations regarding pricing, quality standards, and ethical practices.

Intense Competition: From existing private hospitals, new entrants, and government hospitals, leading to pricing pressure.

Healthcare Professional Shortages: Difficulty in attracting and retaining qualified doctors, nurses, and allied healthcare professionals.

Operational Cost Increases: Rising costs of medical equipment, pharmaceuticals, utilities, and staff salaries.

Medical Malpractice & Litigation Risks: Exposure to legal liabilities related to medical errors or adverse patient outcomes.

Technological Obsolescence: Need for continuous investment in new medical technologies to remain competitive.

Pandemic & Public Health Crises: Unforeseen health crises can disrupt operations and strain resources.

Management & Ownership

As a publicly traded company (implied by the Ticker), Shanmuga Hospital Ltd. would have a professional management team and a board of directors. In many Indian companies, a significant portion of ownership (promoter holding) often resides with the founding families or individuals, who also typically play a key role in management and strategic direction. Management quality would depend on their experience in healthcare operations, financial stewardship, and ability to navigate the complex regulatory and competitive landscape.

Outlook

Shanmuga Hospital Ltd. operates in a sector with structural tailwinds, driven by India's demographic trends, increasing health awareness, and growing affordability of private healthcare. This provides a strong foundation for demand growth. However, the company faces significant challenges including intense competition, the need for continuous capital expenditure for technological upgrades and capacity expansion, and the complexities of healthcare regulations. Sustained growth will depend on its ability to maintain a strong reputation for clinical excellence, attract and retain medical talent, manage operational costs effectively, and strategically expand its services or footprint within its target markets. The ability to differentiate itself from competitors and adapt to evolving patient needs and regulatory environments will be crucial for its long-term success.

Shanmuga Hospital Share Price

Live · BSE · Inception: 2020
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Shanmuga Hospital Quarterly Results

#(Fig in Cr.) Jun 2025 Jun 2026
Net Sales 11 12
Other Income 0 0
Total Income 12 12
Total Expenditure 9 10
Operating Profit 2 2
Interest 0 0
Depreciation 1 1
Exceptional Income / Expenses 0 0
Profit Before Tax 1 1
Provision for Tax 0 0
Profit After Tax 1 1
Adjustments 0 0
Profit After Adjustments 1 1
Adjusted Earnings Per Share 0.7 0.7

Shanmuga Hospital Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 39 37 41 45 23
Other Income 0 0 0 0 0
Total Income 39 37 41 46 24
Total Expenditure 30 30 32 37 19
Operating Profit 9 7 9 8 4
Interest 0 0 1 1 0
Depreciation 0 1 1 2 2
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 9 7 7 6 2
Provision for Tax 2 2 2 1 0
Profit After Tax 7 5 5 4 2
Adjustments 0 0 0 0 0
Profit After Adjustments 7 5 5 4 2
Adjusted Earnings Per Share 0.7 4.9 5.4 3.1 1.4

Shanmuga Hospital Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 7 12 17 40
Minority's Interest 0 0 0 0
Borrowings 0 4 4 4
Other Non-Current Liabilities 0 0 0 1
Total Current Liabilities 4 7 13 9
Total Liabilities 11 23 34 53
Fixed Assets 2 10 16 22
Other Non-Current Assets 0 0 5 0
Total Current Assets 8 13 14 30
Total Assets 11 23 34 53

Shanmuga Hospital Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 1 3 2
Cash Flow from Operating Activities 2 3 10 -13
Cash Flow from Investing Activities -2 -8 -12 -4
Cash Flow from Financing Activities -0 7 1 16
Net Cash Inflow / Outflow 0 2 -1 -1
Closing Cash & Cash Equivalent 1 3 2 1

Shanmuga Hospital Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.69 4.9 5.36 3.09
CEPS(Rs) 0.7 5.5 6.69 4.68
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) 0.73 12.16 17.49 29.16
Core EBITDA Margin(%) 23.21 19.64 21.13 18.14
EBIT Margin(%) 23.1 18.48 18.78 13.9
Pre Tax Margin(%) 23.02 17.73 17.28 12.52
PAT Margin (%) 17.25 12.83 12.92 9.26
Cash Profit Margin (%) 17.59 14.39 16.13 14.01
ROA(%) 63.1 28.27 18.43 9.7
ROE(%) 95.16 50.44 36.25 14.8
ROCE(%) 127.45 51.71 33.45 17.19
Receivable days 44.18 51.99 57.59 59.96
Inventory Days 8.32 12.12 15.85 19.45
Payable days 18.06 26.86 70.3 90.88
PER(x) 0 0 0 10.44
Price/Book(x) 0 0 0 1.11
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) -0.03 0.12 0.41 0.86
EV/Core EBITDA(x) -0.12 0.61 1.87 4.59
Net Sales Growth(%) 0 -4.7 9.47 11.78
EBIT Growth(%) 0 -23.76 11.22 -17.25
PAT Growth(%) 0 -29.11 10.21 -19.85
EPS Growth(%) 0 608.83 9.36 -42.33
Debt/Equity(x) 0 0.65 0.53 0.19
Current Ratio(x) 2.37 1.85 1.05 3.35
Quick Ratio(x) 2.12 1.62 0.9 3.02
Interest Cover(x) 273.49 24.47 12.55 10.08
Total Debt/Mcap(x) 0 0 0 0.17

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +10% +5% — —
Operating Profit CAGR -11% -4% — —
PAT CAGR -20% -17% — —
Share Price CAGR -2% — — —
ROE Average +15% +34% +49% +49%
ROCE Average +17% +34% +57% +57%

Shanmuga Hospital Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 72.06 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 27.94 %
# Dec 2024 Mar 2025 Sep 2025 Mar 2026
Promoter 71.9572.1172.0672.06
FII 00.1900
DII 0000
Public 28.0527.6927.9427.94
Others 0000
Total 100100100100

Shanmuga Hospital Peer Comparison

Hospital & Healthcare Services Edit Columns

Shanmuga Hospital Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Shanmuga Hospital Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 34%
  • Company is almost debt free.

Cons

  • Debtor days have increased from 70.3 to 90.88days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp